Menu
Request a demo

Our products

An agile launch execution platform, with full visibility across countries and functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across countries.
A capability management platform that unifies capabilities, resources, and assessment.
Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.

Our expertise

Launch Readiness

Market Access

Tender Management

Featured Post

6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges

  • Andre Moa
  • 21 Jan 2025
  • 21 minute read

Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.

Read more

Latest posts

Unlocking new growth for your brand with better pharmaceutical tender management

Effective and proactive tender management is critical to capitalising on new growth opportunities for pharmaceuticals and vaccines worldwide.

Read more

5 ways our launch and market access tools will save you time

A smart business tool can save you time to optimise efficiency and market access in a pharma sector swamped with data, communications and multiple inputs.

Read more

A 360˚ view of launch timelines will ease you into the market

Close attention to launch timelines and status will help save you from stumbling at the final hurdle to successful pharma market entry.

Read more

Pharma launch planning should be focused on strategy, not data management

Making the most of pharma launch planning includes ensuring that launch team members are focused on strategic objectives, not data collection and processing.

Read more

Why you need a consistent launch readiness framework

A launch readiness framework is a must to handle pharma market access challenges. You need the tools to ensure a living framework is embedded enterprise wide.

Read more

Launch effectiveness is a patient-access issue

Damaging constraints on patient access to medicines come from many quarters. Pharma companies must ensure that poorly co-ordinated and executed drug launches are not to blame.

Read more

Getting your launch strategy right for today’s market access paradigm

Today’s launch strategies are more modestly scaled, but they must be planned, implemented and tracked in greater depth.

Read more

Pharma launch challenges will only get worse

There is plenty of pharmaceutical innovation left in the tank, judging by current product pipelines. Pharma launch challenges, though, have never been tougher.

Read more

7 pharma trends for 2017 that will define the industry

From pricing concerns, reputational damage control, Trumpian uncertainty, technology convergence to multichannel, we predict the key pharma trends for 2017.

Read more

How are we doing? Tracking pharma product launch ROI through global and local challenges

Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).

Read more

Maintaining pharma ROI as market access bites

By optimising the efficiency and impact of a launch programme, you can maintain ROI from new products at realistic levels that will keep R&D ticking over and continue providing incentives for pharma companies and their investors to pursue better health outcomes.

Read more

Making launches count: pharma ROI under strain

Medicines need to make a profit. Making launches count: pharma and biotech ROI under strain

Read more

Recent Posts

Most Popular Posts

Categories

Get our latest
posts in your inbox

TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.